Scancell (LON:SCLP) Share Price Passes Above 50 Day Moving Average - Here's What Happened

Shares of Scancell Holdings plc (LON:SCLP - Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 10.01 ($0.13) and traded as high as GBX 10.25 ($0.14). Scancell shares last traded at GBX 10 ($0.13), with a volume of 409,111 shares traded.

Scancell Trading Down 4.1%

The business's 50 day moving average price is GBX 10.11 and its two-hundred day moving average price is GBX 9.65. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The company has a market capitalization of £97.10 million, a price-to-earnings ratio of -14.37 and a beta of 0.35.

Insider Activity

In other news, insider Martin Diggle acquired 44,944 shares of the stock in a transaction on Tuesday, May 20th. The shares were purchased at an average cost of GBX 9 ($0.12) per share, for a total transaction of £4,044.96 ($5,447.02). Insiders own 4.96% of the company's stock.

Scancell Company Profile

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.